Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Organization and implementation of an oral cholera vaccination campaign in an endemic urban setting in Dhaka, Bangladesh.

Khan IA, Khan AI, Rahman A, Siddique SA, Islam MT, Bhuiyan MAI, Chowdhury AI, Saha NC, Biswas PK, Saha A, Chowdhury F, Clemens JD, Qadri F.

Glob Health Action. 2019;12(1):1574544. doi: 10.1080/16549716.2019.1574544.

2.

Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh.

Khan IA, Saha A, Chowdhury F, Khan AI, Uddin MJ, Begum YA, Riaz BK, Islam S, Ali M, Luby SP, Clemens JD, Cravioto A, Qadri F.

Vaccine. 2013 Dec 9;31(51):6058-64. doi: 10.1016/j.vaccine.2013.10.021. Epub 2013 Oct 22.

3.

Socioeconomic drivers of vaccine uptake: An analysis of the data of a geographically defined cluster randomized cholera vaccine trial in Bangladesh.

Saha A, Hayen A, Ali M, Rosewell A, MacIntyre CR, Clemens JD, Qadri F.

Vaccine. 2018 Jul 25;36(31):4742-4749. doi: 10.1016/j.vaccine.2018.04.084. Epub 2018 May 8.

4.

Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.

Kar SK, Sah B, Patnaik B, Kim YH, Kerketta AS, Shin S, Rath SB, Ali M, Mogasale V, Khuntia HK, Bhattachan A, You YA, Puri MK, Lopez AL, Maskery B, Nair GB, Clemens JD, Wierzba TF.

PLoS Negl Trop Dis. 2014 Feb 6;8(2):e2629. doi: 10.1371/journal.pntd.0002629. eCollection 2014 Feb.

5.

Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial.

Qadri F, Ali M, Chowdhury F, Khan AI, Saha A, Khan IA, Begum YA, Bhuiyan TR, Chowdhury MI, Uddin MJ, Khan JAM, Chowdhury AI, Rahman A, Siddique SA, Asaduzzaman M, Akter A, Khan A, Ae You Y, Siddik AU, Saha NC, Kabir A, Riaz BK, Biswas SK, Begum F, Unicomb L, Luby SP, Cravioto A, Clemens JD.

Lancet. 2015 Oct 3;386(10001):1362-1371. doi: 10.1016/S0140-6736(15)61140-0. Epub 2015 Jul 9.

PMID:
26164097
6.

Feasibility, coverage and cost of oral cholera vaccination conducted by icddr,b using the existing national immunization service delivery mechanism in rural setting Keraniganj, Bangladesh.

Khan AI, Khan IA, Siddique SA, Rahman A, Islam MT, Bhuiya MAI, Saha NC, Biswas PK, Saha A, Chowdhury F, Qadri F.

Hum Vaccin Immunother. 2019;15(6):1302-1309. doi: 10.1080/21645515.2018.1528833. Epub 2018 Nov 28.

7.

Considerations around the introduction of a cholera vaccine in Bangladesh.

Nelson CB, Mogasale V, Bari TI, Clemens JD.

Vaccine. 2014 Dec 12;32(52):7033-6. doi: 10.1016/j.vaccine.2014.05.028. Epub 2014 May 20.

PMID:
24856784
8.

Knowledge of, attitudes toward, and preventive practices relating to cholera and oral cholera vaccine among urban high-risk groups: findings of a cross-sectional study in Dhaka, Bangladesh.

Wahed T, Kaukab SS, Saha NC, Khan IA, Khanam F, Chowdhury F, Saha A, Khan AI, Siddik AU, Cravioto A, Qadri F, Uddin J.

BMC Public Health. 2013 Mar 19;13:242. doi: 10.1186/1471-2458-13-242.

9.

The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis.

Khan AI, Levin A, Chao DL, DeRoeck D, Dimitrov DT, Khan JAM, Islam MS, Ali M, Islam MT, Sarker AR, Clemens JD, Qadri F.

PLoS Negl Trop Dis. 2018 Oct 9;12(10):e0006652. doi: 10.1371/journal.pntd.0006652. eCollection 2018 Oct.

10.

Safety of the oral cholera vaccine in pregnancy: Retrospective findings from a subgroup following mass vaccination campaign in Dhaka, Bangladesh.

Khan AI, Ali M, Chowdhury F, Saha A, Khan IA, Khan A, Akter A, Asaduzzaman M, Islam MT, Kabir A, You YA, Saha NC, Cravioto A, Clemens JD, Qadri F.

Vaccine. 2017 Mar 13;35(11):1538-1543. doi: 10.1016/j.vaccine.2017.01.080. Epub 2017 Feb 11.

11.

Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia.

Teshome S, Desai S, Kim JH, Belay D, Mogasale V.

Hum Vaccin Immunother. 2018;14(10):2427-2433. doi: 10.1080/21645515.2018.1460295. Epub 2018 May 10.

12.

Neighborhood-targeted and case-triggered use of a single dose of oral cholera vaccine in an urban setting: Feasibility and vaccine coverage.

Parker LA, Rumunu J, Jamet C, Kenyi Y, Lino RL, Wamala JF, Mpairwe AM, Muller V, Llosa AE, Uzzeni F, Luquero FJ, Ciglenecki I, Azman AS.

PLoS Negl Trop Dis. 2017 Jun 8;11(6):e0005652. doi: 10.1371/journal.pntd.0005652. eCollection 2017 Jun.

13.

Oral Cholera Vaccination Delivery Cost in Low- and Middle-Income Countries: An Analysis Based on Systematic Review.

Mogasale V, Ramani E, Wee H, Kim JH.

PLoS Negl Trop Dis. 2016 Dec 8;10(12):e0005124. doi: 10.1371/journal.pntd.0005124. eCollection 2016 Dec. Review.

14.

Estimating the cost of cholera-vaccine delivery from the societal point of view: A case of introduction of cholera vaccine in Bangladesh.

Sarker AR, Islam Z, Khan IA, Saha A, Chowdhury F, Khan AI, Cravioto A, Clemens JD, Qadri F, Khan JA.

Vaccine. 2015 Sep 11;33(38):4916-21. doi: 10.1016/j.vaccine.2015.07.042. Epub 2015 Jul 30.

PMID:
26232545
15.

Safety of a bivalent, killed, whole-cell oral cholera vaccine in pregnant women in Bangladesh: evidence from a randomized placebo-controlled trial.

Khan AI, Ali M, Lynch J, Kabir A, Excler JL, Khan MA, Islam MT, Akter A, Chowdhury F, Saha A, Khan IA, Desai SN, Kim DR, Saha NC, Singh AP, Clemens JD, Qadri F.

BMC Infect Dis. 2019 May 15;19(1):422. doi: 10.1186/s12879-019-4006-3.

16.

A rapid qualitative assessment of oral cholera vaccine anticipated acceptability in a context of resistance towards cholera intervention in Nampula, Mozambique.

Démolis R, Botão C, Heyerdahl LW, Gessner BD, Cavailler P, Sinai C, Magaço A, Le Gargasson JB, Mengel M, Guillermet E.

Vaccine. 2018 Oct 22;36(44):6497-6505. doi: 10.1016/j.vaccine.2017.10.087. Epub 2017 Nov 27.

17.

Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique.

Semá Baltazar C, Rafael F, Langa JPM, Chicumbe S, Cavailler P, Gessner BD, Pezzoli L, Barata A, Zaina D, Inguane DL, Mengel MA, Munier A.

PLoS One. 2018 Oct 3;13(10):e0198592. doi: 10.1371/journal.pone.0198592. eCollection 2018.

18.

Mass vaccination with a two-dose oral cholera vaccine in a refugee camp.

Legros D, Paquet C, Perea W, Marty I, Mugisha NK, Royer H, Neira M, Ivanoff B.

Bull World Health Organ. 1999;77(10):837-42.

19.

Highly targeted cholera vaccination campaigns in urban setting are feasible: The experience in Kalemie, Democratic Republic of Congo.

Massing LA, Aboubakar S, Blake A, Page AL, Cohuet S, Ngandwe A, Mukomena Sompwe E, Ramazani R, Allheimen M, Levaillant P, Lechevalier P, Kashimi M, de la Motte A, Calmejane A, Bouhenia M, Dabire E, Bompangue D, Kebela B, Porten K, Luquero F.

PLoS Negl Trop Dis. 2018 May 7;12(5):e0006369. doi: 10.1371/journal.pntd.0006369. eCollection 2018 May.

20.

Feasibility and acceptability of oral cholera vaccine mass vaccination campaign in response to an outbreak and floods in Malawi.

Msyamboza KP, M'bang'ombe M, Hausi H, Chijuwa A, Nkukumila V, Kubwalo HW, Desai S, Pezzoli L, Legros D.

Pan Afr Med J. 2016 Apr 20;23:203. doi: 10.11604/pamj.2016.23.203.8346. eCollection 2016.

Supplemental Content

Support Center